Hylex Tissues Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 03-01-2025
- Paid Up Capital ₹ 1.84 M
as on 03-01-2025
- Company Age 25 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 5.59 M
as on 03-01-2025
- Revenue -6.67%
(FY 2019)
- Profit 57.77%
(FY 2019)
- Ebitda 4520.54%
(FY 2019)
- Net Worth -270.37%
(FY 2019)
- Total Assets 7.66%
(FY 2019)
About Hylex Tissues
The Company is engaged in the Manufacturing Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 1.84 M.
The company has closed loans amounting to ₹5.59 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Amit Gupta and Anita Gupta serve as directors at the Company.
- CIN/LLPIN
U74999DL1999PTC101501
- Company No.
101501
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Sep 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Hylex Tissues?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Gupta  | Director | 11-Sep-2017 | Current |
| Anita Gupta | Director | 19-Sep-1999 | Current |
Financial Performance of Hylex Tissues.
Hylex Tissues Pvt Ltd, for the financial year ended 2019, experienced Minor drop in revenue, with a 6.67% decrease. The company also saw a substantial improvement in profitability, with a 57.77% increase in profit. The company's net worth observed a substantial decline by a decrease of 270.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Hylex Tissues?
In 2018, Hylex Tissues had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 15 Oct 2012 | ₹1.60 M | Satisfied |
Canara Bank Creation Date: 05 Feb 2010 | ₹2.00 M | Satisfied |
Canara Bank Creation Date: 01 Sep 2007 | ₹0.49 M | Satisfied |
How Many Employees Work at Hylex Tissues?
Unlock and access historical data on people associated with Hylex Tissues, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Hylex Tissues, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hylex Tissues's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
